Moleculin Biotech Inc (MBRX)
US$ 1.77-7.81%
Price Chart
Key Statistics
Market Cap
$ 14.04M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
5.04M
52W High
$ 5.15
52W Low
$ 0.40
Dividend Yield
0.00%
Beta
1.64
Technicals
50-Day MA
0.9998
200-Day MA
1.8526
52 Week High
5.15
52 Week Low
0.3975
About MBRX
Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses.
Employees
17
Headquarters
Houston, TX
CEO
Mr. Walter V. Klemp
Latest News
Moleculin Announces Exercise of Warrants for $5.8 Million Gross Proceeds - PR Newswire
2025-02-13 • Google News
MBRX stock touches 52-week low at $1.46 amid sharp yearly decline - MSN
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg